Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Recent Research: How do angel and venture capital financing compare for startups?

4/3/2022

0 Comments

 
Columbus, OH - According to Ashwin Shenoy, "A team of researchers recently assessed the relationship between angel investing and venture capital (VC) for startups. Although they found some variation in the performance of companies based on their share of angel and VC financing, there was no clear indication that angel investing provides any unique value for a startup."
The research addressed three questions. First, the research analyzed if there are notable differences in the added value to startups when they utilize angel versus VC financing. Second, the research assessed if angel financing and VC financing are substitutes or complements to each other. The last question that the research sought to answer was if the order of angel and VC financing across deal rounds for a startup, referred to as the financing sequence, is related to the probability of a successful exit for the startup.
The research team was comprised of Thomas J. Chemmanur, professor of finance at the Carroll School of Management at Boston College; Harshit Rajaiya, assistant professor of finance at the Tefler School of Management at the University of Ottawa and an alumni of Boston College; and Jiajie Xu, a PhD student in finance at Boston College. The research uses a large sample of financing data primarily from Crunchbase and VentureXpert, as well as datasets from the United States Patent and Trademark Office (USPTO) and the National Establishment Time Series (NETS) database for metrics such as employment and sales.
To address the first research question, angel investors/groups were only included in the sample if they had at least one other investment prior to the investment being analyzed. The purpose of this was to ensure that both the angel and VC investors in the sample were similar in terms of sophistication. The research showed that angel investors that were deemed as sophisticated were less likely to add greater value to a startup than VC investors. Firms with angel financing were also less likely to have successful exits than those with VC financing. "When measured across various industries such as HiTech, manufacturing, and healthcare, this finding remained true," the study found.
To examine if financing from angel investing and venture capital investing are substitutes or complements, the researchers ran a regression to analyze how the participation of angel and VC investors in the first round of financing for a startup affects the participation of these investors in the second round of financing. Therefore, only startups that received at least two rounds of financing are included in this sample – as long as the financing included an angel and/or VC investor.
The results show the share of VC financing in the first round has a strong correlation with VC financing in the second round. This trend is the same for angel financing, where the presence of angel investors in the first round is associated with a higher probability of angel investors being present in the second round. Additionally, the results suggest that the presence of angel financing in the first round is associated with a larger percentage of VC financing in the second round. However, more VC financing in the first round is associated with a small probability of angel investing in the second round.
These results do not provide a clear distinction whether angel and VC investing act as complements or substitutes — they can sometimes act as a complement but sometimes as a substitute. The results, however, do show that the presence of angel investors in the first round is positively associated with VC financing in the second round, while VC financing in the first round is negatively associated with the presence of angel investors in the second round.
For the third question, the researchers measure the success of the startup by analyzing an exit — either via IPOs or acquisitions. Like the previous question, only startups that have received at least two rounds of financing are used in the sample,– as long as there were angel and/or VC investors in those two rounds.
The sample is divided into four groups based on their financing sequence: angel-to-VC, VC-to-angel, VC-to-VC, and angel-to-angel. Startups are divided among these four sequences depending on which type of financing dominated their first and second deal rounds, as long as the dominant type of financing was greater than 50 percent of the total financing in that round.
Firms in the angel-to-VC sequence were 12.3 percent more likely to go public in subsequent years than firms in the angel-to-angel sequence. Additionally, firms in the angel-to-VC and the VC-to-VC sequences were respectively 18.5 percent and 23.9 percent more likely than firms with an angel-to-angel sequence to go public in later years. When measuring for going public, rather than being acquired, these percentages were 28.8 and 23.4, respectively. Firms in the VC-to-angel financing sequence did not have a significant difference in the rate of having a successful exit in subsequent years when compared to firms in the angel-to-angel group.
Relative to companies backed by VC financing, companies with a higher percentage of angel financing had less sales, employment, patents, and exits. Although the researchers control for this by factoring metrics such as company age and sales into their analysis, it is still hard to distinguish these effects based on the deal stage and quality of the company. Startups that need funding but are unable to access it through other means can look to angel investors as a means to further the growth of their company, but there is no clear indication that a startup should specifically pursue financing from angel investors if funding is available – even if the angel investors are considered high-quality and well-known.
The research paper is available for download here.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.